TrialWorld journal of surgical oncology2020

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer.

Mahmoud A Elshenawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.